The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Radio Frequency Wireless Monitoring in Sleep Apnoea (Particularly for Paediatric Patients). Disease diagnosis, chronic disease monitoring and stress monitoring all are limited by diagnostic systems that are attached to patients by wires restricting the recording of such parameters to limited intervals in the clinician's office. The proposed system will enable patients to have a range of physiological parameters recorded without the attachment of wires. This will enable extensive periods of dia ....Radio Frequency Wireless Monitoring in Sleep Apnoea (Particularly for Paediatric Patients). Disease diagnosis, chronic disease monitoring and stress monitoring all are limited by diagnostic systems that are attached to patients by wires restricting the recording of such parameters to limited intervals in the clinician's office. The proposed system will enable patients to have a range of physiological parameters recorded without the attachment of wires. This will enable extensive periods of diagnostic data to be recorded to characterize respiratory, cardiac and other parameters during extended periods, and during normal daily activity. In addition the system can be used to monitor patients with chronic disease and detect trends in their disease.Read moreRead less
Mechanisms of action and expression of bioactive compounds produced by the surface associated marine bacterium Pseudoalteromonas tunicata. The marine surface-associated bacterium Pseudoalteromonas tunicata produces a number of bioactive metabolites that inhibit the colonisation and growth of common fouling organisms such as bacteria, fungi, algae and invertebrate larvae. The antibacterial and antifungal compounds represent novel metabolites active against a remarkable range of both medically and ....Mechanisms of action and expression of bioactive compounds produced by the surface associated marine bacterium Pseudoalteromonas tunicata. The marine surface-associated bacterium Pseudoalteromonas tunicata produces a number of bioactive metabolites that inhibit the colonisation and growth of common fouling organisms such as bacteria, fungi, algae and invertebrate larvae. The antibacterial and antifungal compounds represent novel metabolites active against a remarkable range of both medically and agriculturally important bacteria and fungi. This project aims to explore the identity, mode of action and regulation of expression of these compounds. This research proposal addresses several significant biological concepts and will lead to the development of novel environmentally friendly antifouling and antimicrobial technologies.Read moreRead less
Chemical Defenses Against Microbial Colonisation of Living Marine Surfaces. Microorganisms have a major impact on all ecosystems. Many of these effects are due to the formation of biofilms - cell clusters and their slime matrix - on living and non-living surfaces. Biofilm formation is often regulated by chemical signals. The aim of this project is to understand how naturally produced chemical signals mediate the formation of biofilms on surfaces of marine macroalgae (seaweeds) at both the eco ....Chemical Defenses Against Microbial Colonisation of Living Marine Surfaces. Microorganisms have a major impact on all ecosystems. Many of these effects are due to the formation of biofilms - cell clusters and their slime matrix - on living and non-living surfaces. Biofilm formation is often regulated by chemical signals. The aim of this project is to understand how naturally produced chemical signals mediate the formation of biofilms on surfaces of marine macroalgae (seaweeds) at both the ecological and molecular levels. By understanding colonisation of natural living surfaces, this project will lead directly to significant advances in control of microorganisms in a variety of applied areas (water treatment, biomaterials, antifouling).Read moreRead less
Antiviral compounds to inhibit the replicase of hepatitis C virus. Hepatitis C virus is a major public health problem. There are currently 200,000 infected individuals in Australia and 16,000 new infections every year. There is no specific treatment and current therapy treats a small percentage of patients only, which consists of interferon-alpha and ribavirin. This results in side effects and only a 50% cure rate. This study's outcomes are expected to lead to greater access to treatment and imp ....Antiviral compounds to inhibit the replicase of hepatitis C virus. Hepatitis C virus is a major public health problem. There are currently 200,000 infected individuals in Australia and 16,000 new infections every year. There is no specific treatment and current therapy treats a small percentage of patients only, which consists of interferon-alpha and ribavirin. This results in side effects and only a 50% cure rate. This study's outcomes are expected to lead to greater access to treatment and improved therapy resulting in higher cure rates and in a dramatic reduction in the cost of treating patients. A novel therapy will provide considerable benefits for the national biotechnology industry.Read moreRead less
Environmental genomics and novel bioactives from microbial communities on living marine surfaces. This project has three linked benefits to Australia. One, it is the first study to use environmental genomics analysis in an Australian marine ecosystem, thus bringing into the Australian scientific community the cutting edge technology for studying diverse microbial communities. Two, by using this technology we will be able to investigate Australian marine biodiversity to an unprecedented extent. ....Environmental genomics and novel bioactives from microbial communities on living marine surfaces. This project has three linked benefits to Australia. One, it is the first study to use environmental genomics analysis in an Australian marine ecosystem, thus bringing into the Australian scientific community the cutting edge technology for studying diverse microbial communities. Two, by using this technology we will be able to investigate Australian marine biodiversity to an unprecedented extent. Three, this newly revealed diversity will then be mined for novel bioactives for use in pharmaceutical and other human health applications. Read moreRead less
Biosynthesis of nonribosomal peptide toxins in cyanobacteria: A functional characterisation of microcystin synthetase. Microcystins are potent toxins and tumour promoters produced by cyanobacteria associated with blue-green algal blooms. This non-ribosomal peptide is produced by microcystin synthetase, a unique enzyme complex comprised of peptide synthetases, polyketide synthases, and integrated accessory enzymes. We have identified and characterised the extensive gene cluster encoding this enzy ....Biosynthesis of nonribosomal peptide toxins in cyanobacteria: A functional characterisation of microcystin synthetase. Microcystins are potent toxins and tumour promoters produced by cyanobacteria associated with blue-green algal blooms. This non-ribosomal peptide is produced by microcystin synthetase, a unique enzyme complex comprised of peptide synthetases, polyketide synthases, and integrated accessory enzymes. We have identified and characterised the extensive gene cluster encoding this enzyme. This project describes the biochemical characterisation of specific enzyme activities within microcystin synthetase and how they determine the final structure and toxicity of the many forms of microcystin. Interactions between this enzyme complex and its substrate amino acids will provide information for the genetic engineering of this and similar natural products.Read moreRead less
BIOCATALYSTS MINED FROM CYTOCHROME P450 LIBRARIES: AN INNOVATIVE TOOL FOR ACCELERATING DRUG DEVELOPMENT. The cytochrome P450s (P450s) are a family of enzymes that are perhaps the most versatile biological catalysts known. DNA shuffling is an emerging technique that takes the genes encoding families of enzymes and creates libraries of catalysts with both improved and novel properties. We will obtain proof of concept that shuffled P450 libraries can be screened and optimized for use as biocatalys ....BIOCATALYSTS MINED FROM CYTOCHROME P450 LIBRARIES: AN INNOVATIVE TOOL FOR ACCELERATING DRUG DEVELOPMENT. The cytochrome P450s (P450s) are a family of enzymes that are perhaps the most versatile biological catalysts known. DNA shuffling is an emerging technique that takes the genes encoding families of enzymes and creates libraries of catalysts with both improved and novel properties. We will obtain proof of concept that shuffled P450 libraries can be screened and optimized for use as biocatalysts in drug development. The methodologies developed here will overcome two critical bottlenecks in current drug development: the optimisation and metabolic profiling of new drug candidates. This will yield important benefits in accelerating the optimisation and safety testing of drugs under development.Read moreRead less
Development of therapeutic agents that target carbonic anhydrase enzymes. This research will discover new chemical entities (compounds) that may lead to therapies for the treatment of cancer, glaucoma and malaria. The research underpins a mechanism to add value to our compounds before partnering with industry to transform the discoveries made here to deliverable therapies that could benefit the health of millions, thus offering a potentially high value contribution to the Australian economy. The ....Development of therapeutic agents that target carbonic anhydrase enzymes. This research will discover new chemical entities (compounds) that may lead to therapies for the treatment of cancer, glaucoma and malaria. The research underpins a mechanism to add value to our compounds before partnering with industry to transform the discoveries made here to deliverable therapies that could benefit the health of millions, thus offering a potentially high value contribution to the Australian economy. The experience and commitment of the multi-disciplinary network of researchers offers exceptional training and employment opportunities for tomorrow's scientists in techniques for discovery and characterisation of novel chemicals, and their interaction with disease targets.Read moreRead less
Engineering of anti-platelet antibodies for the diagnosis and therapy of infants with bleeding disorders. Foeto-maternal alloimmune thrombocytopenia (FMAIT) is a serious clinical condition where infants suffer potentially fatal bleeding disorders from 14 weeks gestation to 1-2 weeks post delivery. The cause of the disease is through maternal antibodies destroying foetal platelets. Our aim is to produce human antibodies, which will be used as diagnostic agents to screen for the condition in preg ....Engineering of anti-platelet antibodies for the diagnosis and therapy of infants with bleeding disorders. Foeto-maternal alloimmune thrombocytopenia (FMAIT) is a serious clinical condition where infants suffer potentially fatal bleeding disorders from 14 weeks gestation to 1-2 weeks post delivery. The cause of the disease is through maternal antibodies destroying foetal platelets. Our aim is to produce human antibodies, which will be used as diagnostic agents to screen for the condition in pregnant women, and to further develop such antibodies for therapy. Identification of mothers at risk of FMAIT and the development of a specific therapy are vital to the management and prevention of this serious condition.Read moreRead less
The toxins of water-borne cyanobacteria: regulation and exploitation of their biosynthesis. Water quality is a major concern in Australia, as is the global need for new natural products with antibiotic activity. The mechanisms by which cyanobacteria produce toxins that reduce the quality of water may very well be the answer to the lack of novel medicinal compounds currently being discovered in nature. Encompassed in this one program are the aims of ameliorating the effects of toxic algal blooms ....The toxins of water-borne cyanobacteria: regulation and exploitation of their biosynthesis. Water quality is a major concern in Australia, as is the global need for new natural products with antibiotic activity. The mechanisms by which cyanobacteria produce toxins that reduce the quality of water may very well be the answer to the lack of novel medicinal compounds currently being discovered in nature. Encompassed in this one program are the aims of ameliorating the effects of toxic algal blooms as well as introducing the means for the design and synthesis of a range of novel bioactive products. The benefits include better water quality and biosafety management options, a new generation of drug design and discovery, and the associated transformation of environmental and medical research and education in Australia.Read moreRead less